Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, May 19, 2022
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
Christopher Raymond Maintained (ALXO) at Buy with Decreased Target to $48 on, May 19th, 2022
Christopher Raymond of Piper Sandler, Maintained "ALX Oncology Holdings Inc." (ALXO) at Buy with Decreased Target from $70 to $48 on, May 19th, 2022.
Christopher has made no other calls on ALXO in the last 4 months.
There is 1 other peer that has a rating on ALXO. Out of the 1 peers that are also analyzing ALXO, 0 agree with Christopher's Rating of Hold.
This is the rating of the analyst that currently disagrees with Christopher
- Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $36 on, Tuesday, March 1st, 2022
